Denbright Dental Labs Welcomes New Chief Commercial Officer
Denbright Dental Labs is proud to announce the appointment of Greg Minzenmayer as its new Chief Commercial Officer. His role will encompass overseeing sales, marketing, and the nurturing of organic growth initiatives across the company. This appointment is poised to significantly enhance Denbright’s position as a foremost dental lab partner for both dentists and Dental Service Organizations (DSOs) throughout North America.
Expertise in Dental Industry
Greg Minzenmayer brings over three decades of experience in the dental industry, with 16 of those years dedicated to the dental lab segment. His impressive career exemplifies a history of driving business growth and ensuring operational excellence. He has been a pivotal part of developing and commercializing groundbreaking dental products, including innovations in zirconia, implants, custom prosthetics, and digital technologies.
Prior Experience and Achievements
Prior to this role, Greg held the position of Vice President and General Manager at Osteon Medical, a leading player in the dental implant prosthetics arena. Furthermore, he served as Chief Operating Officer at Glidewell Laboratories, the largest dental laboratory group globally. During his 10-year tenure there, he managed daily operations across multiple labs, leading to tremendous growth and success.
Vision for the Future at Denbright
Upon his appointment, Greg expressed enthusiasm about joining Denbright Dental Labs, stating, "I am thrilled to join Denbright Dental Labs as Chief Commercial Officer. The multiple integrated labs across the platform allow the company to be a great partner for dentists throughout North America, and to service every need a restorative dentist may have." He looks forward to contributing to the company's success and growth.
Support from Leadership
David Casper, the CEO of Denbright, remarked on Greg’s addition to the team, expressing, “I couldn’t be more excited for Greg to join Denbright’s management team. He has an impressive track record of leading and scaling businesses in the dental prosthetics space and adds a tremendous amount of expertise to our team.” This emphasizes Denbright's commitment to executing its strategic initiatives and highlights the strengthening of its already talented management team.
A Comprehensive Overview of Denbright Dental Labs
Denbright Dental Labs is recognized as a leading multi-site dental laboratory, providing a range of high-quality prosthetic solutions. Their offerings include cosmetic dentistry services like full and partial dental prosthetics (including single and multi-unit anterior crowns and bridges, and veneers), general dentistry applications (like posterior crowns and bridges), and implant solutions (for single units and full mouth reconstructions).
Infrastructure and Workforce
The company has invested significantly in creating a robust digital workflow capacity, boasting approximately 180,000 square feet of manufacturing space across its facilities. This growth is complemented by strategic partnerships with trusted offshore manufacturing providers. Employing around 750 staff across seven laboratories, Denbright diligently serves over 10,000 valued customers throughout North America.
About O2 Investment Partners
O2 Investment Partners is a private equity firm located in the Midwest with a focus on investing in lower middle-market niche services, technology, and select industrial companies. The firm seeks opportunities where there is potential for earnings growth and a defined pathway to creating shareholder value. O2’s investment philosophy centers on forming partnerships with management teams to build and enhance businesses, fostering development and executing clear strategic plans for growth.
Frequently Asked Questions
Who is Greg Minzenmayer?
Greg Minzenmayer is the newly appointed Chief Commercial Officer of Denbright Dental Labs, bringing over 30 years of experience in the dental industry.
What are Denbright Dental Labs’ main services?
Denbright Dental Labs offers high-quality dental prosthetics for cosmetic and general dentistry, including implants and removable products.
What is the vision for Denbright with Greg Minzenmayer onboard?
With Greg on the team, Denbright aims to enhance its market presence and continue providing comprehensive solutions for dentists throughout North America.
How many people does Denbright employ?
Denbright employs approximately 750 people across its seven laboratories in North America.
What distinguishes O2 Investment Partners?
O2 Investment Partners focuses on lower middle-market investments with significant growth potential and emphasizes partnership with management teams to drive business success.
